Sectoral Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.13M Buy
27,490
+9,605
+54% +$1.35M 3.42% 6
2025
Q4
$2.2M Sell
17,885
-1,665
-9% -$202K 1.76% 19
2025
Q3
$2.17M Sell
19,550
-140
-0.7% -$15.9K 1.34% 29
2025
Q2
$2.18M Sell
19,690
-12,330
-39% -$1.31M 1.44% 15
2025
Q1
$3.59M Sell
32,020
-19,290
-38% -$1.99M 2.79% 7
2024
Q4
$4.74M Sell
51,310
-9,755
-16% -$878K 3.16% 5
2024
Q3
$5.12M Sell
61,065
-7,760
-11% -$592K 3.02% 5
2024
Q2
$4.72M Buy
68,825
+30,120
+78% +$2.01M 1.92% 14
2024
Q1
$2.84M Sell
38,705
-2,200
-5% -$169K 1.11% 26
2023
Q4
$3.31M Buy
40,905
+2,755
+7% +$214K 1.43% 23
2023
Q3
$2.86M Buy
38,150
+5,468
+17% +$421K 0.56% 76
2023
Q2
$2.52M Buy
32,682
+6,982
+27% +$557K 0.42% 78
2023
Q1
$2.13M Sell
25,700
-350
-1% -$29K 0.41% 79
2022
Q4
$2.24M Sell
26,050
-10,350
-28% -$820K 0.43% 77
2022
Q3
$2.25M Hold
36,400
0.44% 75
2022
Q2
$2.25M Buy
36,400
+11,400
+46% +$706K 0.45% 78
2022
Q1
$1.49M Buy
25,000
+2,100
+9% +$134K 0.26% 87
2021
Q4
$1.66M Sell
22,900
-6,350
-22% -$437K 0.25% 87
2021
Q3
$2.04M Hold
29,250
0.17% 109
2021
Q2
$2.01M Hold
29,250
0.16% 105
2021
Q1
$1.89M Sell
29,250
-300
-1% -$19.3K 0.14% 96
2020
Q4
$1.72M Sell
29,550
-35,350
-54% -$2.13M 0.12% 84
2020
Q3
$4.1M Sell
64,900
-27,250
-30% -$1.89M 0.35% 71
2020
Q2
$7.09M Buy
92,150
+28,500
+45% +$2.18M 0.65% 58
2020
Q1
$4.76M Buy
63,650
+12,300
+24% +$850K 0.91% 49
2019
Q4
$3.34M Sell
51,350
-195,590
-79% -$12.7M 0.5% 52
2019
Q3
$15.7M Sell
246,940
-151,100
-38% -$9.88M 2.7% 9
2019
Q2
$26.9M Sell
398,040
-38,100
-9% -$2.51M 3.22% 8
2019
Q1
$28.4M Buy
436,140
+11,250
+3% +$748K 3.41% 7
2018
Q4
$26.6M Buy
424,890
+158,750
+60% +$11.1M 3.61% 7
2018
Q3
$20.5M Buy
266,140
+1,940
+0.7% +$147K 2.18% 12
2018
Q2
$18.7M Buy
264,200
+59,200
+29% +$4.18M 2.09% 15
2018
Q1
$15.5M Buy
+205,000
New +$16.3M 1.69% 24
2017
Q4
Sell
-234,900
Closed -$19M 68
2017
Q3
$19M Buy
+234,900
New +$18M 2.45% 18
2016
Q4
Sell
-524,165
Closed -$41.5M 57
2016
Q3
$41.5M Buy
524,165
+48,063
+10% +$3.9M 4.07% 6
2016
Q2
$39.7M Sell
476,102
-1,150,662
-71% -$102M 4.1% 6
2016
Q1
$149M Sell
1,626,764
-155,534
-9% -$14M 7.23% 2
2015
Q4
$180M Sell
1,782,298
-74,160
-4% -$7.72M 7.69% 1
2015
Q3
$182M Buy
1,856,458
+552,051
+42% +$61.3M 8.35% 2
2015
Q2
$153M Sell
1,304,407
-16,100
-1% -$1.76M 6.37% 2
2015
Q1
$130M Buy
1,320,507
+636,200
+93% +$64.6M 4.92% 4
2014
Q4
$64.5M Sell
684,307
-625,609
-48% -$64.7M 2.89% 12
2014
Q3
$139M Sell
1,309,916
-189,200
-13% -$18.5M 5.87% 3
2014
Q2
$124M Sell
1,499,116
-558,300
-27% -$43.5M 5.27% 3
2014
Q1
$146M Buy
2,057,416
+115,843
+6% +$9.09M 6% 3
2013
Q4
$146M Sell
1,941,573
-755,114
-28% -$52.6M 6.29% 2
2013
Q3
$170M Sell
2,696,687
-234,270
-8% -$14M 8.16% 1
2013
Q2
$150M Buy
+2,930,957
New +$153M 4.44% 3

Other funds holding GILD

Sectoral Asset Management's GILD Position: Q1 2026 in Review

Sectoral Asset Management increased its Gilead Sciences (GILD) stake by 54% in Q1 2026, buying an estimated $1.35M and bringing the position to 27,490 shares worth $4.13M. The position accounts for 3.42% of the portfolio, ranked #6.

Sectoral Asset Management first reported a position in GILD in Q2 2013 and has held it in 48 quarters since. The position peaked at $182M in Q3 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sectoral Asset Management held 27,490 shares of Gilead Sciences worth $4.13M as of Q1 2026.
  • Sectoral Asset Management bought 9,605 Gilead Sciences shares in Q1 2026, an estimated $1.35M.
  • Gilead Sciences made up 3.42% of Sectoral Asset Management's portfolio in Q1 2026, its #6 holding.
  • Sectoral Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 48 quarters since.
  • Sectoral Asset Management's Gilead Sciences position peaked at $182M in Q3 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.